Extracorporeal right ventricular assist devices can be an effective bridge-to-recovery strategy in selected patients with isolated acute right heart failure due to antiphospholipid syndrome-induced thrombosis.
May inform bridge-to-recovery decisions in rare APS-related right heart failure; leaves open generalizability and need for prospective data.
Antiphospholipid syndrome is an autoimmune disorder with frequent clinical manifestation of arterial, venous or small vessel thromboembolic events and/or foetal morbidity. Hereby, we present a case report of a patient with a large arterial thrombus originating from the ostium of the right coronary artery accompanied by multiple systemic embolization and right ventricular failure. As a bridge-to-recovery strategy, an extracorporeal right ventricular assist device was successfully applied, representing an effective first choice option in selected patients with isolated acute right heart failure.
No takes yet. Share an insight, caveat, or question.
Pólos et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: